Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

<div>Histological section of the kidney on day 70, stained with haematoxylin-eosin: (a) histology for the normal kidney in a mouse treated with physiological saline solution (400x); (b) section of the kidney from a mouse from the group immunised with IMPIPS+adjuvant had microcirculatory changes regarding slight congestion (arrow) (400x).</div>

Journal of Immunology Research

fig4

Figure 4

Figure 4: Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 

Figure 4 | Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 